相似文献
1
Response to neoplastic pericardial effusion.
Clin Cardiol. 2012 Feb;35(2):131-2. doi: 10.1002/clc.21952. Epub 2012 Jan 25.
2
Neoplastic pericardial effusion.
Clin Cardiol. 2011 Oct;34(10):593-8. doi: 10.1002/clc.20936. Epub 2011 Sep 16.
3
Case report: malignant pericardial effusion as the initial manifestation of malignancy.
Am J Med Sci. 1993 Feb;305(2):106-10. doi: 10.1097/00000441-199302000-00009.
4
Cytology of Pericardial Effusion due to Malignancy.
Rom J Intern Med. 2016 Sep 1;54(3):179-183. doi: 10.1515/rjim-2016-0026.
5
[Malignant pericardial effusion].
Harefuah. 1995 May 15;128(10):642-5.
6
Pericardial diseases in patients with cancer: contemporary prevalence, management and outcomes.
Heart. 2020 Apr;106(8):569-574. doi: 10.1136/heartjnl-2019-315852. Epub 2020 Jan 24.
7
Malignant pericardial effusion: still a long way to Ithaca?
Cardiology. 2013;125(1):15-7. doi: 10.1159/000350398. Epub 2013 Apr 19.
8
Neoplastic pericardial effusion. Efficacy and safety of intrapericardial treatment with cisplatin.
Eur Heart J. 2002 Oct;23(20):1625-31. doi: 10.1053/euhj.2002.3328.
9
[Treatment of malignant pericardial effusion].
Gan To Kagaku Ryoho. 2008 Jun;35(6):906-9.
10
Etiology and prognostic implications of a large pericardial effusion in men.
Clin Cardiol. 1988 Jun;11(6):389-94. doi: 10.1002/clc.4960110606.
引用本文的文献
1
The Value of Thin Layer Cytology in Cancer Patients' Pericardial Effusions.
Curr Oncol. 2025 May 26;32(6):306. doi: 10.3390/curroncol32060306.
本文引用的文献
1
Neoplastic pericardial effusion.
Clin Cardiol. 2011 Oct;34(10):593-8. doi: 10.1002/clc.20936. Epub 2011 Sep 16.
2
Neoplastic pericardial disease in lung cancer: impact on outcomes of different treatment strategies. A multicenter study.
Lung Cancer. 2011 Jun;72(3):340-7. doi: 10.1016/j.lungcan.2010.10.013. Epub 2010 Nov 30.
3
A phase I clinical and pharmacokinetic study of paclitaxel liposome infused in non-small cell lung cancer patients with malignant pleural effusions.
Eur J Cancer. 2010 May;46(8):1474-80. doi: 10.1016/j.ejca.2010.02.002. Epub 2010 Mar 6.
4
Pericardiocentesis with cisplatin for malignant pericardial effusion and tamponade.
World J Gastroenterol. 2010 Feb 14;16(6):740-4. doi: 10.3748/wjg.v16.i6.740.
5
The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma.
Diagn Cytopathol. 2010 Dec;38(12):874-9. doi: 10.1002/dc.21303.
6
Challenges in the interpretation of peritoneal cytologic specimens.
Arch Pathol Lab Med. 2009 May;133(5):739-42. doi: 10.5858/133.5.739.
7
Diagnostic utility of pleural fluid carcinoembryonic antigen and CYFRA 21-1 in patients with pleural effusion: a systematic review and meta-analysis.
J Clin Lab Anal. 2007;21(6):398-405. doi: 10.1002/jcla.20208.
8
Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysis.
Thorax. 2008 Jan;63(1):35-41. doi: 10.1136/thx.2007.077958. Epub 2007 Jun 15.
9
Diagnostic effects of prolonged storage on fresh effusion samples.
Diagn Cytopathol. 2007 Jan;35(1):6-11. doi: 10.1002/dc.20587.
10
Intrapericardial cisplatin administration after pericardiocentesis in patients with lung adenocarcinoma and malignant cardiac tamponade.
Hellenic J Cardiol. 2005 Sep-Oct;46(5):324-9.
Zotero 插件